Loading...
XHKG
1696
Market cap142mUSD
Jul 09, Last price  
2.39HKD
1D
3.02%
1Q
-26.01%
IPO
-73.15%
Name

Sisram Medical Ltd

Chart & Performance

D1W1MN
XHKG:1696 chart
P/E
7.51
P/S
0.39
EPS
0.04
Div Yield, %
5.27%
Shrs. gr., 5y
1.16%
Rev. gr., 5y
17.65%
Revenues
365m
+4.65%
101,321,000110,406,000118,156,000136,887,000153,919,000173,520,000162,095,000294,294,000354,480,000359,292,000349,112,000365,347,000
Net income
19m
-24.32%
5,943,0007,814,0008,055,00011,049,00021,831,00020,785,00013,344,00031,245,00040,170,00031,499,00025,126,00019,016,000
CFO
9m
-71.59%
22,807,00015,847,00016,013,00017,057,00016,236,00021,037,00025,737,00032,377,00022,039,00043,936,00033,083,0009,398,000
Dividend
Aug 26, 20250.126 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
IPO date
Sep 19, 2017
Employees
1,102
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT